Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The Headline: MHPAEA Final Rule Effective November 22, 2024
Behavioral health operators should treat the 2024 MHPAEA Final Rule as the single most important payer-facing regulation of the year. The Departments of Labor, HHS, and the Treasury confirm the rule became effective November 22, 2024, with staggered applicability for plan years starting on or after January 1, 2025, and January 1, 2026. Read it before your next commercial payer conversation.
The rule directly targets how commercial plans design and document nonquantitative treatment limitations (NQTLs). Think prior authorization, network admission, out-of-network reimbursement methodology, and level-of-care criteria. CMS lists examples of NQTLs as prior authorization requirements and other medical management techniques, standards related to network composition, and methodologies to determine out-of-network reimbursement rates. Plans now have to demonstrate their MH/SUD NQTLs are comparable, on paper and in operation, to how they handle a comparable medical/surgical service line.
The federal purpose statement is not subtle. The Departments wrote that the rules aim to ensure people seeking coverage for MH conditions or SUDs do not face "greater burdens on access to benefits" than they would face for medical or surgical treatment. That is the enforcement lens.
Operator move for this quarter. Ask your director of utilization management to pull the top three commercial payer contracts and map every UM touchpoint (concurrent review cadence, level-of-care criteria used, peer-to-peer turnaround) against how the same payer handles a comparable medical/surgical service line. If your UM lead cannot produce that comparison from memory, the payer readiness gap is real. Note that the Departments have since paused enforcement of the new-in-2024 provisions pending litigation, but the statutory MHPAEA obligations, as amended by the CAA, 2021, continue to have effect. Do not read the enforcement pause as a compliance holiday.
The M&A Reset: Fewer Deals, Bigger Checks
Behavioral health M&A in late 2024 is not slowing down. It is re-sorting. OPEN MINDS reported 67 behavioral health M&A deals in the U.S. For the 12 months ending November 15, 2024, a 19% decline in deal volume, while total deal value hit $400 million, an increase of 324% over the prior year. Fewer sellers are getting to close. The ones that do are commanding more capital.
The public-market read points the same direction. VMG Health noted that Acadia, the largest pure-play behavioral health provider in the U.S. And Puerto Rico, operates across 40 states with 258 treatment facilities and over 11,400 beds as of the end of Q3 2024, while UHS operates 186 inpatient behavioral health facilities in the U.S. Plus 144 in the UK. Meanwhile, UHS CFO Steve Filton told analysts that rising interest rates have "substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms" and paused UHS’s acquisition appetite. Big strategics are sitting. Sponsor-backed platforms with clean data rooms are transacting.
What that means for a founder in Florida, Texas, or Tennessee thinking about a 2025 sale. Buyers are underwriting harder on quality of earnings, payer concentration, and compliance history. A sloppy licensure file or an open state finding will not just trim your multiple. It can collapse the deal. Founders should complete the feasibility study, the pro forma reconciliation, and the mock survey before signing the engagement letter with a banker, not after.
Federal Enforcement: The Signal Every Operator Should Read
DOJ, HHS-OIG, CMS, DEA, and state Medicaid Fraud Control Units have made behavioral health a named enforcement priority, and data analytics is the front door. The 2024 National Health Care Fraud Enforcement Action charged 193 defendants, including 76 doctors, nurse practitioners, and other licensed medical professionals in 32 federal districts, involving approximately $2.75 billion in intended losses and $1.6 billion in actual losses. The pattern is worth studying whether or not your organization touches Medicaid.
The 2025 follow-on takedown made the trajectory obvious. In the Eastern District of Virginia, the co-owner of a mental health company was charged with a $49 million Virginia Medicaid fraud scheme that targeted the homeless by offering hotel stays in exchange for using their Medicaid numbers to bill for crisis stabilization services that were not needed or received. In the District of Arizona, a defendant was charged with submitting $44 million in fraudulent claims for behavioral services, primarily targeting Native Americans struggling with substance abuse. Both matters live inside the behavioral health service definition, and both used documentation drift as the fraud vehicle.
The methodology has changed. DOJ noted that data analysis established that patients were hospitalized at other institutions on days the defendant billed for behavioral health services, and prosecutors opened the investigation within five days of the financial intelligence review. A regional MFCU pulling a claims dataset and seeing a therapist billing 14 hours a day on days a client was inpatient elsewhere is now a five-day file, not a five-month one.
The operator takeaway is not "we are not fraudsters, this does not apply." It is that documentation drift, meaning group notes that read identically across ten clients, IOP attendance for clients who were in residential the same day, biopsychosocials signed before intake, will now surface in an analytics pass long before it surfaces in a chart audit. Run your own same-day service overlap report and duplicate-note audit before an SIU audit or a state MFCU does it for you.
The Demand Data Underneath All of This
Operators building pro formas for 2025 need real numerator and denominator data, not vibes. SAMHSA’s 2023 National Survey on Drug Use and Health found that nearly 25% of adults reported experiencing any mental illness in 2023, and 17.1% of the U.S. Population aged 12 or older (approximately 48.5 million individuals) met the criteria for substance use disorder. The unmet-need story is not marketing copy. It is a federal survey.
The treatment gap is bigger than most pro formas assume. Among the 48.5 million people aged 12 or older with an SUD in 2023, only 15.6% (7.1 million people) received treatment, while 85.4% (41.1 million people) did not. On the medication side specifically, a JAMA-published analysis found that only 18% of individuals with OUD received MOUD in 2023. Those are your addressable-market numbers, and they are also the numbers CMS and DOL will look at when they evaluate whether commercial NQTLs are producing material differences in access.
Two operational implications. First, MAT-inclusive programs in states with functional Medicaid managed care (think Ohio, Pennsylvania, Georgia) have a payer story that the 2024 MHPAEA rule strengthens, because plans denying MOUD access under stricter NQTLs than they apply to medical/surgical benefits are exactly the fact pattern DOL and CMS enforcement is looking for. Second, if your ASAM Criteria 4th Edition level-of-care mix skews entirely to residential without a defensible outpatient step-down through partial hospitalization (Level 2.5) and intensive outpatient (Level 2.1), you are underbuilt for how commercial payers now approve length of stay.
What Operators Should Actually Do This Month
Five items to close before December 15.
- Payer readiness audit. Pull your NQTL exposure by payer: prior authorization triggers, concurrent review timing, level-of-care determination criteria, out-of-network reimbursement methodology. Cross-reference against the DOL fact sheet on the MHPAEA final rules.
- ASAM 4th Edition alignment. Confirm your clinical documentation, admission criteria, and continued-stay criteria reference the current edition, not carryover language from the 3rd. Surveyor focus is shifting to current-edition language.
- Mock survey and EOC tour. If your team has not walked the Environment of Care as a surveyor would in the last 90 days, do it. Findings from a mock survey are cheaper than findings from a real one.
- Data-driven claims review. Have your billing team run a same-day service overlap report and a duplicate-note audit. Do the analytics on yourself before HHS-OIG or a state MFCU does.
- Deal readiness, even if you are not selling. Clean licensure files, current accreditation, three years of quality-of-earnings-ready financials. The buyers who move in Q1 will pay for readiness and discount for anything less.
Frequently asked questions
When did the 2024 MHPAEA Final Rule take effect, and does it apply to my treatment center?
The rule became effective November 22, 2024, with staggered applicability for plan years starting on or after January 1, 2025, and January 1, 2026, per the Departments of Labor, HHS, and Treasury. It regulates group health plans and issuers directly, not treatment providers, but it changes how your commercial payers must design and document prior authorization, level-of-care criteria, and network admission decisions. Note that the Departments have paused enforcement of the new-in-2024 provisions pending litigation, but the underlying MHPAEA statutory obligations, as amended by the CAA, 2021, remain in effect.
How active was behavioral health M&A heading into late 2024?
OPEN MINDS reported 67 U.S. Behavioral health M&A deals in the 12 months ending November 15, 2024, a 19% decline in volume, but total deal value climbed to $400 million, up 324% over the prior year. Fewer transactions closed. The ones that did were larger and more competitive, with buyers underwriting harder on payer mix, compliance history, and quality of earnings.
What are federal enforcement agencies focused on in behavioral health right now?
DOJ, HHS-OIG, CMS, DEA, and state Medicaid Fraud Control Units are coordinating across dozens of federal districts and using data analytics to open cases. The 2024 enforcement action charged 193 defendants involving $2.75 billion in intended losses. Recent behavioral health cases include a $49 million Virginia Medicaid crisis stabilization fraud scheme and a $44 million Arizona behavioral services scheme targeting Native Americans. Operators should run their own same-day service overlap and documentation audits proactively.
What ASAM Criteria edition should our program be documenting to?
The ASAM Criteria 4th Edition is the current standard used by AHS. Programs still using 3rd Edition level names and numbers will draw surveyor focus and payer questions during utilization review. Confirm your admission, continued-stay, and discharge criteria have been rewritten to match current level-of-care definitions before your next survey window or payer credentialing cycle. When in doubt, describe the level of care in plain clinical terms rather than assert a legacy number.
References
- U.S. Departments of Labor, HHS, and Treasury: Statement on Enforcement of the 2024 MHPAEA Final Rule
- DOL Fact Sheet: Final Rules under the Mental Health Parity and Addiction Equity Act (MHPAEA)
- CMS: The Mental Health Parity and Addiction Equity Act (MHPAEA)
- Federal Register: Requirements Related to the MHPAEA (Effective November 22, 2024)
- OPEN MINDS: Behavioral Health Deal Values Grew by 324% in 2024
- VMG Health: 2024 Review of Behavioral Health M&A Transactions & Trends
- HHS-OIG: 2024 National Health Care Fraud Enforcement Action (193 defendants, $2.75B)
- DOJ: 2025 National Health Care Fraud Takedown (Virginia $49M and Arizona $44M behavioral health cases)
- SAMHSA: 2023 National Survey on Drug Use and Health Key Findings
- SAMHSA: Results from the 2023 NSDUH (Full Report)